A meta-analysis of 13 independent microarray data sets was performed and gene expression profiles from cystic fibrosis (CF), similar disorders (COPD: chronic obstructive pulmonary disease, IPF: idiopathic pulmonary fibrosis, asthma), environmental conditions (smoking, epithelial injury), related cellular processes (epithelial differentiation/regeneration), and non-respiratory "control" conditions (schizophrenia, dieting), were compared. Similarity among differentially expressed (DE) gene lists was assessed using a permutation test, and a clustergram was constructed, identifying common gene markers. Global gene expression values were standardized using a novel approach, revealing that similarities between independent data sets run deeper than shared DE genes. Correlation of gene expression values identified putative gene regulators of the CF transmembrane conductance regulator (CFTR) gene, of potential therapeutic significance. Our study provides a novel perspective on CF epithelial gene expression in the context of other lung disorders and conditions, and highlights the contribution of differentiation/EMT and injury to gene signatures of respiratory disease.
Introduction
A legacy of standardized microarray data reporting [11] is an ever-growing archive of transcriptomic data sets which are available for reanalysis and comparison, thereby enabling integration of data from diverse sources that, by themselves, might not provide a full picture of underlying biological processes. Recent meta-analyses of cystic fibrosis (CF)-related gene expression [13, 20] suggest that identification of underlying similarities or specific gene signatures in closely related studies can be thwarted by variability in source materials, distinct methodologies and different microarray platforms. These limitations echo studies in cancer, where the plasticity of molecular signatures is a well described phenomenon [45] that has delayed the implementation of their diagnostic/prognostic potential [55] . Nevertheless, comparison of global gene expression data in related tissues under different conditions might provide valuable insights into the shared pathological pathways and regulatory networks dysregulated in individual diseases.
CF, an autosomal recessive genetic disorder caused primarily by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein [43] , is characterized by a progressive lung disease brought about by dehydration of the epithelial airway surface liquid (ASL) and a failure of mucociliary clearance, leading to recurrent bacterial infections and a chronic inflammatory response [16] . Some clinical features of CF are shared by obstructive lung diseases such as chronic obstructive pulmonary disorder (COPD: [42] ) and asthma [39] , with airway surface dehydration [33] and chronic inflammation [3] implicated in the pathology of all three of these disorders. The interstitial lung disease idiopathic pulmonary fibrosis (IPF) is also a chronic inflammatory condition with a fibrotic component, like CF [15] . Furthermore, recent studies have shown that a CF-like disorder can be induced by exposure to cigarette smoke, which causes CFTR protein to be internalized from the apical membrane of airway epithelium [14] . This "acquired" CF-like condition can be an aggravating or confounding factor in the diseases mentioned above [41] . It is therefore clear that while CF itself is brought about by absence of functional CFTR protein, many of its symptoms are generalized for a variety of lung conditions, since compensatory changes in gene expression downstream of the loss of the functional CFTR chloride channel are masked by secondary changes related to the progression of CF-related lung disease. Meta-analysis of a group of individual microarray studies might allow us to assess the affinities between respiratory disorders at the level of the transcriptome and the respective regulatory networks.
In this study we assessed the similarity of independent gene expression microarray data sets from lung diseases and related conditions, using our own data from CF nasal epithelium [13] as a starting point, and including data from 12 other studies, including non-respiratory conditions as "negative controls". We examined the similarity between lists of differentially expressed (DE) genes using a permutation test, and identified a cluster of such genes common to independent data sets. We then used a novel data standardization approach and multidimensional scaling to assess the similarity of global gene expression and the overall relative distances between data sets and their constituent samples. Finally, by correlating the standardized expression of the CFTR gene with that of all other genes common to all samples we were able to identify potential regulators of F508del-CFTR expression, and perform validation using siRNA knockdown. Our data suggest that a significant part of the changes in gene expression observed in the CF airway epithelium are common to other respiratory diseases and represent shared processes like epithelial-mesenchymal transition (EMT), injury, and inflammation.
Results

Data
The 13 microarray data sets chosen for reanalysis are summarized in Table 1 . Besides our own nasal epithelial cell study [13] , we chose 2 other CF data sets, one measuring gene expression in bronchial epithelial brushings [38] , and one in fetal tracheal cell lines [56] . We added other studies measuring gene expression in chronic lung diseases, namely chronic obstructive pulmonary disorder (COPD: [7] ), idiopathic pulmonary fibrosis (IPF: [35] ) and asthma [29] , with the first two of these studies using whole lung tissues, and the last airway epithelial brushings. The effect of smoking in human bronchial epithelial brushings was represented by two studies [31, 50] , included because of recent findings that cigarette smoke exposure can induce a CF like disorder [14] . Data sets representing airway epithelial cell differentiation following exposure of bronchial epithelial cell lines to an air-liquid interface [40, 46] and repair of airway epithelial injury [22] were included to investigate the contribution of these components in airway disease transcriptomes, and because regeneration of epithelia in CF has been found to be "delayed and abnormal" [19] . Two studies on unrelated disorders were chosen to function as "negative controls", i.e., to detect potential similarities between data sets with little functional relevance to each other. These investigated the effect of schizophrenia on gene expression in brain tissue [28] and the effect of dieting on gene expression in adipose tissue [37] . The thirteen studies used four different microarray platforms, of which three were from Affymetrix (HsAirway_a520108F, HG-U133A and HG-U133_Plus2) and one from Illumina (HumanRef-8 v1).
Comparison of reanalyzed gene lists
Differentially expressed genes obtained following reanalysis of 13 multiple independent studies (Table 1) were identified (Supplementary File 1) and a clustergram of genes appearing in 5 or more separate lists (excluding the two "negative control" studies) was constructed ( Fig. 1) , with the direction of differential gene expression categorized as either "CF-like" (for disease phenotypes and undifferentiated/injured cells) or "Control-like" (for control phenotypes and differentiated cells). The clustergram includes 74 DE genes which may represent generalized markers of chronic inflammatory lung disease, including but not exclusively CF. Twenty seven of these genes were more often up-regulated in "CF-like" phenotypes, and significant (p b 0.05) numbers of them were associated with the inflammatory response (n = 9), wounding (n = 10), defense response (n = 10) and regulation of cell proliferation (n = 10) GO terms (DAVID: [25] ), were expressed in the extracellular space (n = 11), or possessed cytokine activity (n = 7). Forty-three clustergram genes were more highly expressed in "Control-like" phenotypes (i.e., down-regulated in disease), and included significant (p b 0.05) association of genes with antigen presentation (n = 5), immune response (n = 8), and MHC Class II protein complex (n = 4) GO terms. Three genes present on the clustergram, including S100A8, an inflammation marker, formerly known as one half of the "CF antigen" [5] were up-regulated equally in "CF-like" and "Control-like" conditions. Many of the disease markers identified in this comparison are hallmarks of epithelial differentiation [40, 46] or injury [22] , as indicated by their inclusion in gene lists from those studies, and a striking number of upregulated genes, e.g., in CF epithelium, are associated with the undifferentiated phenotype.
Gene list overlap permutation analysis
The probabilities that observed DE gene list overlaps between independent microarray studies were greater than would be expected by chance (with "expected" overlaps being calculated in a permutation test using 1000 randomly generated pairs of gene lists per comparison) and were calculated for all studies against our CF nasal cell data set [13] , and are presented in Table 2 . Examination of the data reveals a tendency for DE gene lists from other relevant studies to show a significant overlap with the CF gene list, for similar phenotypes: for example, the observed overlaps between [13] possible comparisons are presented in Supplementary File 2, and summarized in Table 3 , revealing that certain gene lists (e.g., [35] _UP (IPF) and [50] _DOWN (Smoking), which have highly significant overlaps with 16 other gene lists of any direction) were much richer in shared regulated genes than others (e.g., [29] _UP, which has no overlaps at the highest level of significance with any other gene list).
Interestingly, the data sets we chose as "negative controls", where the phenotypes and tissues under study were judged to be irrelevant to respiratory epithelial biology and therefore less likely to produce significantly greater than random overlaps [28, 37] , did overlap significantly with a number of experimental data sets, thereby providing a caveat for such assumptions. Nevertheless, Table 3 shows that only the asthma Table 1 ). For differentiation studies (R, P) undifferentiated cells are considered to be "CF-like" and differentiated cells "Control-like". Genes are clustered according to whether they are predominantly up-regulated in "CF-like" phenotypes (27 genes: upper section), "Control-like" phenotypes (43 genes: lower section), or is equally represented (3 genes: central section between lines). study [29] had less total overlaps at the highest level of significance than the two "negative control" studies, mainly due to the uniqueness of the up-regulated gene list from that study. A schematic diagram of highly significant overlaps among all 13 studies is presented in Fig. 2 , in which it can be seen that there is a high level of overlap in both upand down-regulated gene lists between roughly half of the studies, namely the in vivo CF, smoking, injury and differentiation studies, with the "controls", asthma, IPF, COPD and cell line CF studies comprising a less connected half of the diagram.
Standardized global gene expression data
Standardized gene expression values for 7837 genes (including CFTR) common to all 13 re-analyzed studies were generated by a novel method (see Supplementary File 3). The average positions of samples from reanalyzed studies projected in 2D space based on MDS applied to standardized global gene expression values are shown in Fig. 3 . The samples were divided into control (A) and treatment (B) groups, and divided into subgroups (a/b suffixes) if clear sample Table 2 Permutation analysis of overlap between DE gene lists from 12 studies and CF nasal cell data set [13] .Observed overlaps (i.e., number of identical shared genes, collapsed from multiple probesets if relevant) between gene lists shown at left (named as first author of studies described in Table 1 , plus direction of differential expression) and up-or down-regulated gene lists from [13] : numbers in brackets indicate sizes of gene lists. N (perm. N obs.) indicates number of times observed overlap was exceeded in 1000 random permutations of the same overlap. P values are adjusted for multiple testing, and the maximum significance level (N (perm. N obs.)=0) highlighted in black. . Arrows (C) show movement through 2D space from mean position of control samples to mean position of treated samples, for each study. Some similarities in the position and movement of samples in this space were noted. For example, global CF-related gene expression in nasal cells [13] produced similar positions, and therefore shared overall movement through 2D space between control and treated groups, with COPD [7] and epithelial injury [22] , while the undifferentiated samples in the two differentiation studies [40, 46] were located in the same position as the disease samples of these three studies, in agreement with the significant overlaps of differentially expressed genes shown in Table 2 and Supplementary File 2 for the disease/undifferentiated phenotypes. However, unlike the data on DE gene list overlaps, the positions shown here are based on global gene expression, with expression values of 7837 common genes given equal weight regardless of differential expression profile, and given the methodological differences between independent studies, the concurrences are therefore all the more remarkable. Similarities and differences between standardized data from each study are also shown in the global correlation of gene expression among all samples from all studies with each gene contributing equal weight (D), where the shading can be used to assess the influence of array type on the extent of global correlation between data sets.
Correlation of standardized gene expression values
Pearson's correlation coefficients (R) for standardized expression values were calculated for all 7836 common genes vs. CFTR, in each of the 13 re-analyzed studies for all samples, and in each CF study, for F508del samples only. Weighted mean Pearson's R values (±SEM) for the 100 most highly negatively correlated genes in each case are given in Supplementary File 4. Several of the genes that negatively correlated with CFTR expression across all studies have been previously described to affect CFTR expression. The most highly negatively correlated gene, YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta) positively regulates CFTR biosynthesis [32] and binds to the CFTR regulatory (R) domain [10] , but is also suspected to delay airway epithelial remodeling via positive regulation of MMP1 (matrix metalloproteinase 1) expression [2] . The next gene, AP2M1 (adaptor-related protein complex 2, mu 1 subunit), has been identified in a high-content functional screen as a corrector of CFTR [53] . The presence of two previously identified positive CFTR regulators at the very top of our list of negative CFTR correlators suggests that their enhanced expression might be triggered by reduced CFTR expression as a compensatory mechanism. The list of genes negatively correlated with F508del-CFTR expression values only was also rich in genes with possible links to CFTR function or to localizations or processes that might implicate them in CFTR trafficking (see Supplementary File 4) . SNAP23 (synaptosomalassociated protein, 23 kDa), for example, is part of CFTR's SNARE interactome, and regulates CFTR gating [52] , whereas FAS (Fas cell surface death receptor), the next gene on the list, is a known modulator of CF disease severity [30] , which has been found to be crucial to regulation of CFTR-dependent apoptosis and autophagy following epithelial injury induced by cigarette smoke [8] .
siRNA knockdown of potential CFTR regulators
We tested the effect of siRNA knockdown on F508del-CFTR trafficking for 73 genes whose expression was negatively correlated with either F508del-CFTR only (n = 38) or with CFTR across all studies (n = 38: 3 common genes, see Supplementary File 4). For nine of the 73 genes tested, siRNA knockdown produced appreciable increases in CFTR traffic to the plasma membrane (median Z score N 1: see Supplementary File 4 and Table 4) in our assay. For most products of these genes, a direct role in CFTR traffic regulation is hard to ascribe, although some are involved in maintaining an undifferentiated phenotype. The protein tyrosine phosphatases PTP4A1/2 have both been implicated in cell motility and invasiveness signaling [44] , while NMT1 (N-myristoyltransferase 1) and MGA (MAX dimerization protein) are both involved in cell proliferation [17, 26] . There is no evidence for a functional link between GNAQ (guanine nucleotide binding protein (G protein) q polypeptide) and CFTR, but PSEN1 (presenilin 1) is a member of the gamma secretase complex, and therefore may have a role in proteolysis [18] . RCN2 (reticulocalbin 2), an ER calcium binding protein, has been described as a member of the CFTR interactome [58] . Rho target PKN2 is crucial to the formation of apical cell junctions in differentiating bronchial epithelium [57] , and SNX6 (sorting nexin 6) is a retromer component which regulates protein transport from the endosome to the transGolgi network (TGN: [24, 36] ).
Discussion
This study presents the meta-analysis of 13 microarray data sets, of which 11 are related to respiratory disease and epithelial differentiation, and functionally relevant to the study of cystic fibrosis (CF)-related gene Table 1 ), and grouped into a more highly connected half (left) and a less connected half (right).
expression. The other two studies were chosen for their presumed lack of a pathological basis for similarity with the other data sets and were thus used as "negative controls". Our analysis has enabled the comparison of independent microarray studies with respect to their differential gene expression and standardized global gene expression, and allowed us to identify some potential novel gene regulators of CFTR.
Clustergram -shared markers and common processes
The identity of the DE genes shared by different studies and the degree to which certain diseases/processes share them can best be appreciated in the clustergram (Fig. 1) , where the genes most frequently appearing on independent gene lists are displayed. GO term enrichment analysis associated the genes up-regulated in CF-like phenotypes with functional categories highly relevant to CF lung pathology (e.g., inflammation, defense, wounding, proliferation, cytokine activity), and identified down-regulation of antigen presentation and immune response genes, as previously described for CF [20] . The general trend is for up-regulated genes to be shared by CF [13, 38] and COPD [7] , perhaps reflecting the pro-inflammatory airway phenotype secondary to CFTR dysfunction, as several of these DE genes are also present in injured [22] or undifferentiated cells [40, 46] . On the Table 4 Genes for which siRNA knockdown produced an appreciable increase in CFTR traffic to the plasma membrane in CFBE cells (median Z score N1: see Supplementary File 4).
Gene
Correlation list Median Z-score Function other hand, a prominent set of genes down-regulated in injured and undifferentiated cells corresponds to genes which are downregulated either in CF in vivo [13, 38] , or in smoking studies [31, 50] , suggesting the possibility that they represent genes repressed by a lack of functional CFTR protein, although the pattern of the in vitro CF study [56] does not support this trend. The clustergram also clearly identifies conditions which do not fit these tendencies: for example, many genes up-regulated in IPF [35] and down-regulated in asthma [29] invert the direction of expression seen in other conditions, namely in CF and COPD. From our data, it is not clear whether such inversions would be perpetuated in other studies of the same diseases, and therefore represent robust differences in gene expression profiles between CF/COPD and asthma or IPF. Our data provide a novel perspective by revealing the extent to which genes or their functional groups, some of which have previously been identified as candidate marker genes for CF, are CF-specific (e.g., RGS2: regulator of G-protein signaling 2, G0S2: G0/G1 switch 2), or else are revealed as general markers of respiratory inflammation (e.g., IL1R2: interleukin 1 receptor, type II, IL8: interleukin 8). Upregulated expression of four genes (SPP1: secreted phosphoprotein 1, AREG: amphiregulin, C15ORF48: chromosome 15 open reading frame 48, and TM4SF1: transmembrane 4L six family member 1) was found to be associated with CF-like phenotypes only, and may provide interesting clues for further investigation of a potential differentiation defect in the CF epithelium [19] . Indeed, all four of these genes have been associated with cancer lethality, progression or invasiveness [48, 49, 51, 61] , and this finding is interesting in the light of CFTR's own role in suppressing tumor progression [60] . Of the six genes associated exclusively with "Control-like" gene lists (i.e., down-regulated in disease), SEC14L3 (SEC14-like 3 (Saccharomyces cerevisiae)) stands out for playing an important role in lung development [23] , and is known to have an inverse relationship with allergic airway inflammation [47] , whereas DNALI1 (dynein, axonemal, light intermediate chain 1) is an essential component of motile respiratory cilia [62] . The functional significance of the other genes exclusively down-regulated in our clustergram (PTGFR: prostaglandin F receptor, PROS1: protein S (alpha), MAOB: monoamine oxidase B, FABP6: fatty acid binding protein 6, ileal) is less clear, although as a group these six genes are down-regulated in in vivo CF, smoking and epithelial injury, thereby potentially representing a gene signature linking those conditions. Finally, the DE gene which appears in the greatest number of independent gene lists (3 "CF-like", 5 "Control-like"), TMEM45a, has been described as a marker for keratinization [21] , and its regulation in several of the studies analyzed here also suggests a role in airway epithelium differentiation.
We conclude that the differential gene expression pattern in CF is most closely related to that of COPD, smoking, injury and (de-)differentiation. Despite heterogeneity between studies, our clustergram presents a coherent molecular signature for various airway conditions that associates airway inflammation, de-differentiation and injury with up-regulation of specific genes, while hinting that loss of functional CFTR may underlie the down-regulation of others.
Permutation analysis: DE gene overlap significance
We have attempted to determine the extent to which gene lists from independent studies with phenotypic relevance to one another overlap more than predicted by randomly generated gene lists, using a permutation test. Not all overlaps between "similar" gene lists were significantly greater than random (see Table 2 and Supplementary File 2): for example, up-regulated gene lists from CF nasal cells [13] and COPD lung [7] overlapped with the highest level of significance, but downregulated gene lists from these two studies did not. Nevertheless, many similarities were detected between independent studies which presumably signify shared biological processes. The inclusion of data sets representing epithelial injury [22] and differentiation [40, 46] allowed us to identify genes involved in those processes as being associated with DE gene expression in airway disorders. In particular, the number of DE genes shared between these studies and in vivo CF data sets [13, 38] is striking, and reveals a significant injury and dedifferentiation or epithelial-mesenchymal transition (EMT) signature in CF epithelium, associating CFTR dysfunction with perturbed differentiation pathways [19] . This is further highlighted in Fig. 2 , where we show that the in vivo CF studies are highly associated (with respect to DE gene list similarity) with smoking, injury and de-differentiation.
The two "control" studies [28, 37] also overlapped significantly with other studies in certain cases (see Table 3 and Supplementary File 2) , showing that many biological processes share common pathways and DE genes despite being superficially unrelated, and that these common processes may compromise attempts to identify lists of DE marker genes unique to any particular process or disease. Indeed, both "control" studies originally reported changes in gene expression, and specifically down-regulation of mitochondrial genes, both in adipose tissue following dieting [37] and in brain tissue of schizophrenic individuals [28] . Since CF is also associated with reduced mitochondrial function [54] , some DE gene overlap between the "control" studies and the CF studies can therefore be expected, and the same may be true for other lung diseases [1] .
Standardized global gene expression
The standardized data based on expression values of 7837 common genes across all studies and microarray platforms are shown in MDS plots in 2D-space giving an approximation of "closeness" among data sets split between the phenotypes compared (Fig. 3) . It can be noted that our CF nasal cell study [13] has the same position in both control and experimental samples as COPD [7] and epithelial injury [22] , suggesting that the differences between control and experimental phenotypes in these three studies therefore represent a similar global shift in the transcriptome. It is also noticeable that certain groups of samples cluster together in the MDS plot. For example, the control (undifferentiated) samples of the differentiation studies [40, 46] lie in a similar position to the experimental CF [13] , injury [22] and COPD [7] samples, which makes sense in the context of the permutation test results for the DE gene overlaps between those studies. Other superimpositions and overall movements are harder to interpret, including the mismatch in position between the in vivo CF studies [13, 38] , but it must be borne in mind that all 7837 genes were given the same weight in this analysis (see Supplementary File 3) . It is therefore notable that the majority of control and experimental samples can easily be discriminated by this global measure of expression, implying that disease-related gene expression represents a global "tilt" of the transcriptome, and not just changes in a few hundred DE genes. Thus, the agreements between certain studies for similarity data based on DE gene list overlaps on the one hand and standardized global gene expression values on the other are remarkable. It is also worth noting that the influence of array type, which could have been a strong determinant of sample position, was minimized by our standardization (see Fig. 3D ). Despite this, the differing and even inverted positions of some of the studies in Fig. 3 may also represent systematic differences in overall gene expression values that derive from materials and methodologies specific to independent studies, rather than reflecting underlying biological differences between conditions or airway diseases.
Identification of potential CFTR regulators
In a preliminary siRNA knockdown assay we have identified some potential negative regulators of CFTR traffic (Table 4 ) whose expression was highly inversely correlated with CFTR expression, either across all studies, or in the subset of samples expressing F508del-CFTR (Supplementary File 4). The correlation of gene expression values with those of CFTR across many experimental and control samples in several independent studies is likely to be fraught by the effects of variability, but the presence of several proven CFTR regulators and interactome members on our lists partly validates the approach. Potential CFTR gene regulators identified by siRNA knockdown in a CFBE model of F508del-CFTR traffic rescue include the retromer component SNX6 (sorting nexin 6: [59] ), which might cross the path of wild type CFTR in the early endosome, during recycling, although negative correlation with F508del-CFTR was also found. Another negative CFTR correlator, PSEN1 (presenilin 1), is implicated, as a potential gamma secretase component, in a protease network regulating expression of CXCR1 surface expression on neutrophils, and their IL8-mediated recruitment [4] , and therefore may be of therapeutic interest in CF. RCN2 (reticulocalbin 2) encodes a calcium binding protein in the ER lumen, where F508del-CFTR, with which it is negatively correlated, mediates the chloride conductance that is responsible for the enhanced Ca 2+ -dependent chloride (Cl − ) conductance (CaCC) seen in CF epithelia [34] . Reduced expression of this CFTR interacting protein [58] might therefore lead to enhanced CFTR expression via interference in the CaCC feedback loop. Confirmation of these and other such interactions between gene expression of our proposed potential regulators and maturation and traffic of the F508del-CFTR protein will require much further work, and the lists we present are rich in untested potential leads, worthy of future investigation.
Conclusions
We have used archived gene expression data to extend our knowledge about the relationships between the transcriptomes of related respiratory conditions, and have thereby supplied a novel perspective on airway pathophysiology. Our meta-analysis of 13 microarray data sets has allowed us to perform a comparative analysis of CFrelated differential gene expression in the context of other respiratory diseases and conditions, including smoking, and the allied processes of differentiation and injury. We have found genes associated with dedifferentiation and epithelial injury to be strongly associated with the CF gene expression profile, and we have confirmed that exposure to cigarette smoke, with its down-regulation of CFTR expression, causes a gene expression profile with many affinities to that of CF. Furthermore, we show that the affinities between certain independent studies (e.g., CF, COPD and injury) hold true not only for DE genes but also for global gene expression values, suggesting that similarities between related conditions run deeper than just a few perturbed pathways. Using standardized gene expression correlation we have also been able to propose potential regulators of CFTR expression which may be of future interest in the design of novel strategies for rescue of mutant CFTR protein.
Materials and methods
Microarray data reanalysis
Affymetrix Genechip expression data (see Table 1 ) were quantile normalized in RMA Express [27] and the Ilumina data set [38] was reanalyzed with alternative tools using similar methods as previously described [13] . Prior to normalization, quality control (QC) parameters (GAPDH ratios, log 2 PM distributions and RLE/NUSE plots) were examined to determine sample inclusion, independent of QC decisions made by the original authors. Samples used in reanalysis are presented in Supplementary File 1. Normalized values were then analyzed using the Rank Products method ( [12] ; Bioconductor Package RankProd). Variable cutoffs with a starting point of pfp b 0.01, p b 0.0001, and FC N 2 were used to choose lists of differentially expressed (DE) genes from each study not exceeding 500 genes in length. The criteria used and the DE genes chosen for each study are given in Supplementary File 1. A clustergram was constructed based on genes appearing most frequently in lists of both up-and down-regulated genes. For the clustergram, phenotypes for which a gene was preferentially expressed were categorized as either "CF-like" (e.g., genes up-regulated in CF, COPD, Asthma, IPF, smoking, injury studies) or "Control-like" (e.g., genes down-regulated in those studies). For the differentiation studies [40, 46] , the undifferentiated and differentiated phenotypes were considered to be "CF-like" and "Control-like", respectively, so genes up-regulated in cells differentiating at the air-liquid interface (ALI) were grouped with genes down-regulated in CF and related diseases, and vice versa.
GO term enrichment analysis
We submitted gene lists to the online bioinformatic resource DAVID [25] for enrichment analysis of GO terms, making use of the following categories: BP_Fat (biological process), CC-Fat (cellular component) and MF_Fat (molecular function), against the default Homo sapiens background. Benjamini-Hochberg-corrected p values were used to determine significance [6] .
Overlap permutation statistical analysis
In order to test the null hypothesis that the number of differentially expressed genes shared between different studies was no different from the number that would be shared by random selections of genes from the same microarrays, we developed a permutation-based methodology. Gene lists (up or down with respect to the particular phenotype relevant to each study) were collapsed to single gene symbols and the total number of genes appearing in any two compared lists ("overlap") was counted for all lists from all studies and for both directions of differential expression. The observed overlap for each pair of lists was compared with that in 1000 randomly generated gene list pairs (also collapsed to single gene symbols), with the sizes of each observed list and the relevant microarray backgrounds being taken into account for each comparison. Multiple testing adjusted p values were calculated using the Benjamini and Hochberg procedure [6] .
Standardization of microarray data sets and comparison of global gene expression data
For comparison of global values of gene expression between all 13 re-analyzed studies, data sets were reduced to 7837 common genes (including CFTR) represented by varying numbers of probes on each of the four microarray platforms used in the 13 studies (Affymetrix HsAirway, HG-U133A, HG-U133A plus2, and Illumina HumanRef-8 v1). The RMA-normalized expression values for these common genes were standardized by a novel method described in detail in Supplementary File 3. We then conducted a two-dimensional projection of cases using multidimensional scaling, in order to assess global similarities between data sets. Standardized expression values as calculated above for all 7836 shared genes (excluding CFTR) were then correlated (Pearson's R) with the corresponding expression values for CFTR itself (see Supplementary File 4). This was done for all 13 studies (n = 252 samples including both experimental and control groups), and also for a subset of F508del expressing samples from the three CF studies (n = 16 samples). Representative genes of interest showing a strong negative correlation to CFTR or F508del CFTR expression were selected for siRNA knockdown assays to test their effect on F508del-CFTR traffic correction in a CFBE epithelial cell model.
siRNA knockdowns and CFTR trafficking assay
An assay to test the effect of siRNA knockdown on trafficking of F508del-CFTR traffic to the plasma membrane was performed for 73 genes (identified in Supplementary File 4) in a CF bronchial epithelial (CFBE) cell model as previously described [9] . The chosen genes were equally divided between those found to have a high mean negative correlation with CFTR expression in all studies, and in F508del-CFTR expressing samples only.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.ygeno.2015.07.005.
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